切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2021, Vol. 14 ›› Issue (03): 181 -186. doi: 10.3877/cma.j.issn.1674-6899.2021.03.011

综述 上一篇    下一篇

食管胃结合部腺癌的微创外科治疗现状与展望
胡志豪 1, 李瑞欣 1, 王国俊 1 , ( )   
  1. 1. 450001 郑州大学第一附属医院胃肠外科
  • 收稿日期:2021-04-24 出版日期:2021-08-18
  • 通信作者: 王国俊

Current status and perspectives of minimally invasive surgical treatment of adenocarcinoma of esophagogastric junction

Zhihao Hu 1, Ruixin Li 1, Guojun Wang 1 , ( )   

  1. 1. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, China
  • Received:2021-04-24 Published:2021-08-18
  • Corresponding author: Guojun Wang

食管胃结合部腺癌(adenocarcinoma of esophagogastric junction,AEG)发病率不断升高,外科手术仍然是最重要和有效的治疗方法。传统开放手术创伤大、恢复慢,而腹腔镜、胸腔镜及纵隔镜技术的迅速发展促进了食管胃结合部腺癌的微创外科治疗。为进一步减少手术创伤,机器人辅助手术及经自然腔道取标本手术等新技术也在陆续开展。未来AEG的微创化治疗将得到进一步规范和推广。

The incidence of adenocarcinoma of esophagogastric junction (AEG) has been increasing gradually, while surgical treatment is still the most important and effective therapy. Traditional open surgery is associated with large trauma and slow recovery, and the rapid development of laparoscopic, thoracoscopic and mediastinoscopic techniques has promoted the minimally invasive surgical treatment of adenocarcinoma of esophagogastric junction. To further reduce surgical trauma, new techniques such as robot-assisted surgery and natural orifice specimen extraction surgery are also being developed, and minimally invasive treatment of AEG will be further standardized and promoted in the future.

1
Steevens J, Botterweck AA, Dirx MJ, et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe[J]. Eur J Gastroenterol Hepatol, 2010,22(6): 669-678.
2
Colquhoun A, Arnold M, Ferlay J, et al. Global patterns of cardia and non-cardia gastric cancer incidence in 2012[J]. Gut, 2015,64(12): 1881-1888.
3
Imamura Y, Watanabe M, Toihata T, et al. Recent incidence trend of surgically resected esophagogastric junction adenocarcinoma and microsatellite instability status in japanese patients[J]. Digestion, 2019,99(1): 6-13.
4
Rüdiger Siewert J, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1 002 consecutive patients[J]. Ann Surg, 2000,232(3): 353-361.
5
Bernabe KQ, Bolton JS, Richardson WS. Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case-control study[J]. Surg Endosc, 2005,19(3): 334-337.
6
Perry KA, Enestvedt CK, Pham T, et al. Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage Ⅰ esophageal adenocarcinoma[J]. Arch Surg, 2009,144(7): 679-684.
7
Maas KW, Biere SS, Scheepers JJ, et al. Laparoscopic versus open transhiatal esophagectomy for distal and junction cancer[J]. Rev Esp Enferm Dig, 2012,104(4): 197-202.
8
Cash JC, Zehetner J, Hedayati B, et al. Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer[J]. Surg Endosc, 2014,28(2): 492-499.
9
陈克能,马少华,梁震,等. 经膈肌裂孔食管切除术治疗食管癌及食管胃交界癌的远期疗效[J]. 中华胃肠外科杂志,2010,13(9): 649-651.
10
Parry K, Ruurda JP, Sluis PC, et al. Current status of laparoscopic transhiatal esophagectomy for esophageal cancer patients: a systematic review of the literature[J]. Dis Esophagus, 2017,30(1): 1-7.
11
Hulscher JB, Sandick JW, Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus[J]. N Engl J Med, 2002,347(21): 1662-1669.
12
Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial[J]. Ann Surg, 2007,246(6): 992-1000.
13
Fujiwara H, Shiozaki A, Konishi H, et al. Transmediastinal approach for esophageal cancer: a new trend toward radical surgery[J]. Asian J Endosc Surg, 2019,12(1): 30-36.
14
Davies AR, Forshaw MJ, Khan AA, et al. Transhiatal esophagectomy in a high volume institution[J]. World J Surg Oncol, 2008,6(1): 88-88.
15
张国亮,米丽丽,曾辉,等. 腹腔镜下食管内翻拔脱术治疗早期食管癌的临床分析[J]. 重庆医学,2017,46(20): 2835-2837.
16
张葆勋,于磊,伍冀湘,等. 两种微创手术方式治疗颈段食管癌的对比研究[J]. 中国医刊,2019,54(5): 516-520.
17
Straatman J, Wielen N, Cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the time trial[J]. Ann Surg, 2017,266(2): 232-236.
18
Honda M, Kuriyama A, Noma H, et al. Hand-sewn versus mechanical esophagogastric anastomosis after esophagectomy: a systematic review and meta-analysis[J]. Ann Surg, 2013,257(2): 238-248.
19
Cadière GB, Dapri G, Himpens J, et al. Ivor lewis esophagectomy with manual esogastric anastomosis by thoracoscopy in prone position and laparoscopy[J]. Surg Endosc, 2010,24(6): 1482-1485.
20
Elshaer M, Gravante G, Tang CB, et al. Totally minimally invasive two-stage esophagectomy with intrathoracic hand-sewn anastomosis: short-term clinical and oncological outcomes[J]. Dis Esophagus, 2018.DOI: 10.1093/dote/dox150
21
曹庆东,代伟,杨军,等. 经口置入钉砧头系统(OrVil)在全腔镜下食管癌根治术中消化道重建中的应用体会[J]. 中国微创外科杂志,2010,10(12): 1130-1132.
22
罗晓阳,陈海泉,相加庆,等. 利用OrVil经口输送钉砧系统行胸腹腔镜Ivor Lewis食管癌根治术[J]. 中国癌症杂志,2010,20(6): 471-473.
23
Ben-David K, Tuttle R, Kukar M, et al. Minimally invasive esophagectomy utilizing a stapled side-to-side anastomosis is safe in the western patient population[J]. Ann Surg Oncol, 2016,23(9): 3056-3062.
24
Irino T, Tsai JA, Ericson J, et al. Thoracoscopic side-to-side esophagogastrostomy by use of linear stapler-a simplified technique facilitating a minimally invasive ivor-lewis operation[J]. Langenbecks Arch Surg, 2016,401(3): 315-322.
25
Wang F, Zhang H, Zheng Y, et al. Intrathoracic side-to-side esophagogastrostomy with a linear stapler and barbed suture in robot-assisted ivor lewis esophagectomy[J]. J Surg Oncol, 2019,120(7): 1142-1147.
26
Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients[J]. Ann Surg, 2012,256(1): 95-103.
27
Workum F, Maas J, Wildenberg FJ, et al. Improved functional results after minimally invasive esophagectomy: intrathoracic versus cervical anastomosis[J]. Ann Thorac Surg, 2017,103(1): 267-273.
28
Buess G, Becker HD. Minimally invasive surgery in tumors of the esophagus[J]. Langenbecks Arch Chir Suppl Ⅱ Verh Dtsch Ges Chir,1990, 118: 1355-1360.
29
Wang J, Jiang NQ, Jiang B, et al. Mediastinoscopy-assisted oesophagectomy in T1 oesophageal cancer patients with serious comorbidities: a 5-year long-term follow-up[J]. Interact Cardiovasc Thorac Surg, 2015,20(4): 477-481.
30
Jin Y, Lu X, Xue L, et al. Retrospective comparison of two minimally invasive esophagectomy in the treatment of esophageal cancer: pneumatic mediastinoscopy versus thoracoscopy[J]. J Laparoendosc Adv Surg Tech A, 2019,29(5): 638-642.
31
Liu W, Guo X, Zhao H, et al. Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: a single-center initial experience[J]. J Thorac Dis, 2020,12(9): 4908-4914.
32
谭黎杰,徐正浪,仇德惠,等. 电视纵隔镜辅助食管切除术安全性探讨[J]. 中国微创外科杂志,2003,3(5): 406-407.
33
袁勇,陈心足,胡建昆,等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版)解读[J]. 中华胃肠外科杂志,2019,22(2): 101-106.
34
柳常青,解明然,郭明发,等. 胸腹腔镜联合微创治疗Siewert Ⅱ型食管胃交界腺癌的近期结果[J]. 中华外科杂志,2016,54(6): 461-465.
35
张俊,李珍,张同钦,等. 胸腹腔镜微创术与开放Sweet食管切除术对Siewert Ⅱ型食管胃交界腺癌手术创伤的影响[J]. 中国医学装备,2020,17(12): 101-105.
36
杜泽森,傅俊惠,郑春鹏,等. 胸腹腔镜联合切除Siewert Ⅱ型食管胃交界部腺癌48例[J]. 肿瘤防治研究,2014,41(11): 1234-1236.
37
Li KK, Bao T, Wang YJ, et al. The postoperative outcomes of thoracoscopic-laparoscopic ivor-lewis surgery plus D2 celiac lymphadenectomy for patients with adenocarcinoma of the esophagogastric junction[J]. Surg Endosc, 2020,34(11): 4957-4966.
38
Wang Q, Wu Z, Zhan T, et al. Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis[J]. BMC Cancer, 2019,19(1): 500-500.
39
李国雷,王保华,李忠,等. 微创Ivor-Lewis食管切除术与Sweet手术治疗Siewert Ⅱ型食管胃结合部腺癌的前瞻性对比研究[J]. 中国微创外科杂志,2020,20(8): 686-690.
40
Wu H, Shang L, Du F, et al. Transhiatal versus transthoracic surgical approach for siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis[J]. Expert Rev Gastroenterol Hepatol, 2020,14(11): 1107-1117.
41
Hong L, Han Y, Jin Y, et al. The short-term outcome in esophagogastric junctional adenocarcinoma patients receiving total gastrectomy: laparoscopic versus open gastrectomy--a retrospective cohort study[J]. Int J Surg, 2013,11(9): 957-961.
42
Sugita S, Kinoshita T, Kaito A, et al. Short-term outcomes after laparoscopic versus open transhiatal resection of siewert type Ⅱ adenocarcinoma of the esophagogastric junction[J]. Surg Endosc, 2018,32(1): 383-390.
43
Huang CM, Lv CB, Lin JX, et al. Laparoscopic-assisted versus open total gastrectomy for siewert type Ⅱ and Ⅲ esophagogastric junction carcinoma: a propensity score-matched case-control study[J]. Surg Endosc, 2017,31(9): 3495-3503.
44
Zhao Y, Zhang J, Yang D, et al. Feasibility of laparoscopic total gastrectomy for advanced siewert type Ⅱ and type Ⅲ esophagogastric junction carcinoma: a propensity score-matched case-control study[J]. Asian J Surg, 2019,42(8): 805-813.
45
Sugita S, Kinoshita T, Kuwata T, et al. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type Ⅱ adenocarcinoma of the esophagogastric junction[J]. Surg Endosc, 2021,35(1): 340-348.
46
Nguyen NT, Roberts P, Follette DM, et al. Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures[J]. J Am Coll Surg, 2003,197(6): 902-913.
47
McCahill LE, May M, Morrow JB, et al. Esophagectomy outcomes at a mid-volume cancer center utilizing prospective multidisciplinary care and a 2-surgeon team approach[J]. Am J Surg, 2014,207(3): 380-386.
48
Takiguchi S, Miyazaki Y, Shinno N, et al. Laparoscopic mediastinal dissection via an open left diaphragm approach for advanced siewert type Ⅱ adenocarcinoma[J]. Surg Today, 2016,46(1): 129-134.
49
刘天舟,马志明,佟倜,等. 全腹腔镜下经胸腔入路治疗Siewert型食管胃结合部腺癌[J]. 中华胃肠外科杂志,2017,20(9): 1054-1054.
50
余盼攀,张健,孔文成,等. 完全腹腔镜经腹经膈肌裂孔入路在Siewert Ⅱ型食管胃结合部腺癌根治术中的应用价值[J]. 中华消化外科杂志,2019,18(6): 587-593.
51
郑民华,臧潞,马君俊,等. Siewert Ⅱ型食管胃结合部腺癌腔镜手术治疗中国专家共识(2019版)[J]. 中国实用外科杂志,2019,39(11): 1129-1135.
52
Palanivelu C, Prakash A, Parthasarathi R, et al. Laparoscopic esophagogastrectomy without thoracic or cervical access for adenocarcinoma of the gastroesophageal junction: an indian experience from a tertiary center[J]. Surg Endosc, 2007,21(1): 16-20.
53
王自强,张元川,张倩,等. 腹腔镜下经膈肌裂孔食管胃切除治疗食管胃交界癌55例[J]. 中华胃肠外科杂志,2010,13(9): 652-655.
54
王自强,张元川,邓祥兵,等. 腹腔镜经食管裂孔行扩大胃切除术治疗Ⅱ和Ⅲ型食管胃交界癌[J]. 中华消化外科杂志,2012,11(1): 61-65.
55
Liao C, Feng Q, Xie S, et al. Laparoscopic versus open gastrectomy for Siewert type Ⅱ/Ⅲ adenocarcinoma of the esophagogastric junction: a meta-analysis[J]. Surg Endosc, 2021,35(2): 860-871.
56
胡永利. 腹腔镜辅助与开腹根治性全胃切除术对Siewert Ⅱ、Ⅲ型食管胃结合部腺癌疗效的临床研究[D]. 福建医科大学,2018.
57
李国雷,王保华,闫红江,等. 微创Ivor-Lewis食管切除术在食管胃结合部腺癌中的应用[J]. 中国微创外科杂志,2020,20(4): 289-292.
58
Sluis PC, Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial[J]. Ann Surg, 2019,269(4): 621-630.
59
Jin D, Yao L, Yu J, et al. Robotic-assisted minimally invasive esophagectomy versus the conventional minimally invasive one: a meta-analysis and systematic review[J]. Int J Med Robot, 2019,15(3): 1988.
60
Zheng C, Li XK, Zhang C, et al. Comparison of short-term clinical outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy: a systematic review and meta-analysis[J]. J Thorac Dis, 2021,13(2): 708-719.
61
廖存香,冯青,李平昂,等. 达芬奇机器人手术系统、腹腔镜与开腹手术治疗局部进展期Siewert Ⅱ型和Ⅲ型食管胃结合部腺癌近期疗效对比研究[J]. 中华消化外科杂志,2020,19(6): 620-629.
62
王道胜,曹守根,谭晓杰,等. 机器人与腹腔镜辅助手术对Siewert Ⅱ型食管胃结合部腺癌淋巴结清扫及近期结局的影响[J]. 中华胃肠外科杂志,2019,22(2): 156-163.
63
王绪宁,柯沐,徐茂林,等. 机器人与腹腔镜辅助Siewert Ⅲ型食管胃结合部腺癌根治术的近期疗效比较[J]. 军事医学,2020,44(10): 773-778.
64
Hüscher CG, Lirici MM, Ponzano C. NOSE laparoscopic gastrectomies for early gastric cancer may reduce morbidity and hospital stay: early results from a prospective nonrandomized study[J]. Minim Invasive Ther Allied Technol, 2017,26(2): 71-77.
65
刘金超,于刚,荣震. 经自然腔道取出标本的全腹腔镜远端胃癌根治术(Uncut Roux-en-Y吻合)七例报告[J/CD]. 中华结直肠疾病电子杂志,2018,7(4): 381-384.
66
曲辉,孙国瑞,汤小龙,等. 完全腹腔镜下经自然腔道取出标本的胃癌根治术+直肠癌根治术1例报告[J]. 腹腔镜外科杂志,2018,23(12): 955-957.
67
何鹏辉,刘东宁,鞠后琼,等. 腹部无辅助切口经阴道取标本的全机器人远端胃切除术(GC-NOSES Ⅳ式)[J/CD]. 中华腔镜外科杂志(电子版),2021,14(1): 49-52.
68
丁恒轩,李瑞欣,孙俊锋,等. 隐形切口在腹腔镜胃癌根治术中的应用[J]. 中国实用医刊,2019,46(19): 24-26.
[1] 张耀, 高峥嵘, 张强, 赵昌松, 陈佳敏, 赵汝岗, 马睿. 微创手术治疗18例布鲁菌病髋关节炎合并早期股骨头坏死的疗效[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(04): 281-287.
[2] 丁相元, 任效瑛, 闫慧明. 微创胰十二指肠切除术治疗胰腺导管腺癌围手术期和近远期疗效的Meta分析[J]. 中华普通外科学文献(电子版), 2021, 15(04): 313-320.
[3] 李东亮, 王伟, 周家杰, 杜瑞, 王峰, 佟贵繁, 丁旭, 汪刘华, 汤东, 王道荣. 自带抗反流装置管型胃在SiewertⅡ型和Ⅲ型食管胃结合部腺癌中临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2021, 15(02): 157-161.
[4] 朱可安, 陈灵, 李昭, 黄薇. 应用单孔腹腔镜开展常见妇科手术的可行性探讨[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 158-162.
[5] 朱中飞, 何天霖. 达芬奇机器人脾动脉瘤切除重建一例[J]. 中华腔镜外科杂志(电子版), 2021, 14(02): 112-115.
[6] 何鹏辉, 刘东宁, 鞠后琼, 仲崇晗, 李太原. 腹部无辅助切口经阴道取标本的全机器人远端胃切除术(GC-NOSES Ⅳ式)[J]. 中华腔镜外科杂志(电子版), 2021, 14(01): 49-52.
[7] 胡俊熙, 陈良亮, 束余声. 吲哚菁绿荧光成像技术在胸外科的应用[J]. 中华腔镜外科杂志(电子版), 2021, 14(01): 61-64.
[8] 中国医师协会结直肠肿瘤专业委员会NOTES专委会. 经自然腔道内镜手术(NOTES)专家共识[J]. 中华结直肠疾病电子杂志, 2021, 10(04): 337-342.
[9] 汤庆超, 王锡山. 浅谈应用达芬奇机器人手术平台开展直肠癌NOSES手术的优越性和局限性[J]. 中华结直肠疾病电子杂志, 2021, 10(04): 343-350.
[10] 刘孟承, 黄贲, 任志鹏, 冷株赟, 高玮, 朱哲, 韩俊毅, 周主青, 傅传刚. 超重直肠癌患者NOSES手术可行性的影响因素分析[J]. 中华结直肠疾病电子杂志, 2021, 10(03): 243-249.
[11] 关旭, 焦帅, 黄海洋, 周海涛, 傅传刚, 韦烨, 熊治国, 孙东辉, 陈路川, 蔡建春, 何庆泗, 马丹, 郑阳春, 丁克峰, 胡军红, 彭健, 姚宏亮, 王贵玉, 汪泳, 孙学军, 李太原, 江波, 康亮, 王锡山. 中国经自然腔道取标本手术开展现状分析[J]. 中华结直肠疾病电子杂志, 2021, 10(02): 122-131.
[12] 姜浩, 郁雷, 陈瑞, 张浩, 盛祥宗, 管子龙, 姜巍, 高峰. NOSES Ⅱ式与常规腹腔镜中位直肠癌根治术疗效对比[J]. 中华结直肠疾病电子杂志, 2021, 10(02): 187-193.
[13] 周军, 赵月明, 宋常华, 赵志明, 仲伟明, 邓昌武, 张聿民, 李树志. 神经内镜手术治疗自发性幕上中等程度脑出血的临床效果[J]. 中华神经创伤外科电子杂志, 2021, 07(01): 51-55.
[14] 王述民. 机器人手术十年体会[J]. 中华胸部外科电子杂志, 2021, 08(01): 1-5.
[15] 冷雪峰, 郭旭峰, 戴亮, 侯广杰, 大幸宏幸, 韩泳涛. 日本国立癌症中心食管外科访学浅谈及启示[J]. 中华胸部外科电子杂志, 2021, 08(01): 63-69.
阅读次数
全文


摘要